CYHB1950135 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs | Supplementary Application | 2019-01-29 | 深圳翰宇药业股份有限公司 | Hybio Pharmaceutical Co Ltd | Certificate Issued | 2021-08-27 | view |
CYHS1900913 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3) | Generic Drug | 2020-01-08 | 海南普利制药股份有限公司 | Hainan Poly Pharm Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHS1900047 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3) | Generic Drug | 2019-01-26 | 江苏诺泰澳赛诺生物制药股份有限公司 | Jiangsu Sinopep-Allsino Biopharmaceutical Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHS1900912 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3) | Generic Drug | 2020-01-08 | 海南普利制药股份有限公司 | Hainan Poly Pharm Co Ltd | Certificate Issued | 2021-02-09 | view |
CYHS1700193 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3) | Generic Drug | 2017-09-30 | 成都圣诺生物制药有限公司 | Chengdu Shengnuo Biopharm Co Ltd | Certificate Issued | 2020-12-16 | view |
CYHS2000417 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3) | Generic Drug | 2020-07-04 | 南京健友生化制药股份有限公司 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | In Review | 2020-07-02 | view |
CYHS1900064 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3) | Generic Drug | 2019-01-26 | 海南双成药业股份有限公司 | Hainan Shuangcheng Pharmaceuticals Co Ltd | In Review | 2019-01-23 | view |
CYHB1608615 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs | Supplementary Application | 2017-11-03 | 深圳翰宇药业股份有限公司 | Hybio Pharmaceutical Co Ltd | Certificate Issued | 2018-08-13 | view |
CYHS1700115 | 依替巴肽 | eptifibatide | Active ingredient | Chemical Drugs(3) | Generic Drug | 2017-09-30 | 成都圣诺生物制药有限公司 | Chengdu Shengnuo Biopharm Co Ltd | In Review | 2017-09-28 | view |
CXHL1400464 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3.4) | New Drug Application | 2014-04-30 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-03-24 | view |
CXHL1400463 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3.4) | New Drug Application | 2014-04-30 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-03-24 | view |
CYHS1401554 | 依替巴肽 | eptifibatide | Active ingredient | Chemical Drugs(6) | Generic Drug | 2015-04-17 | 哈尔滨吉象隆生物技术有限公司 | Harbin Jixianglong Biotechnology Co Ltd | In Review | 2015-04-15 | view |
CXHS0900272 | 爱啡肽 | eptifibatide | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2010-03-23 | 深圳市翰宇药业有限公司 | Hybio Pharmaceutical Co Ltd | Certificate Issued | 2015-01-15 | view |
CYHB1305336 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs | Supplementary Application | 2014-02-19 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2014-09-30 | view |
CXHS1100271 | 依替巴肽 | eptifibatide | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2012-05-30 | 海南双成药业股份有限公司 | Hainan Shuangcheng Pharmaceuticals Co Ltd | Certificate Issued | 2014-01-21 | view |
CXHS1100272 | 注射用依替巴肽(曾用名:注射用依非巴特) | eptifibatide | Lyophilized | Chemical Drugs(3.1) | New Drug Application | 2012-05-30 | 海南双成药业股份有限公司 | Hainan Shuangcheng Pharmaceuticals Co Ltd | Certificate Issued | 2014-01-21 | view |
CYHB1104512 | 依替巴肽 | eptifibatide | Active ingredient | Chemical Drugs | Supplementary Application | 2011-05-27 | 江苏豪森医药集团连云港宏创医药有限公司 | Lianyungang Hongchuang Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | 2013-01-08 | view |
CXHB1200031 | 依替巴肽 | eptifibatide | Active ingredient | Chemical Drugs | Supplementary Application | 2012-04-01 | 江苏豪森医药集团连云港宏创医药有限公司 | Lianyungang Hongchuang Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | 2012-11-30 | view |
CXHS0800268 | 依替巴肽 | eptifibatide | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2009-01-05 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2012-11-06 | view |
CXHS0800270 | 依替巴肽注射液 | eptifibatide | Injection | Chemical Drugs(3.1) | New Drug Application | 2009-01-05 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2012-11-06 | view |